Intellipharmaceutics International Inc. (Nasdaq: IPCI), announced that it had reached an agreement with AstraZeneca (NYSE: AZN) to settle all outstanding ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE